View Cart  

Drug IP Protection Could See Boost Under Bill to Speed Rare Disease Treatments

A A
Manufacturer and patient groups are urging Congress to pass the MODDERN Cures Act, which would increase possible financial rewards for companies developing treatments for rare conditions.

To View This Article:

Login

Subscribe To Drug Industry Daily